Treatment of osteoporosis: why, whom, when and how  to treat

Seeman, Ego; Eisman, John A

doi:10.5694/j.1326-5377.2004.tb06283.x

Topics

Women's health

Ego Seeman,* John A Eisman†

1 Austin Hospital, Studley Road, Heidelberg, VIC 3084.
2 and Director, Bone and Mineral Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW.

Correspondence: egos@unimelb.edu.au

Competing interests:

E S has been paid to sit on medical advisory boards for Aventis, Eli Lilly, and Merck Sharp & Dohme; J A E has been a paid consultant for Aventis, Eli Lilly, Merck Sharp & Dohme, NPS (USA), Organon, Roche and Servier.

1. Dawson-Hughes B, Harris SS, Krall A, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 1997; 337: 670-676.
2. Matkovic V, Kostial K, Simonovic I, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutrition 1979; 32: 540-549.
3. Shea B, Wells G, Cranney A, et al. Osteoporosis Methodology Group; Osteoporosis Research Advisory Group. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 2004; 1: CD004526.
4. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1728-1733.
5. Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly people. Ann Intern Med 1996; 124: 400-406.

Online responses are no longer available. Please refer to our instructions for authors page for more information.